By Steve Hanley from CleanTechnica —- Worried that alterations to the Earth’s climate may wipe out all the bees, leading to a steep decline in the availability of fruits and vegetables? Fear not. Researchers at MIT say they have successfully created robot bees that can do the job of real bees just as well and maybe better in some cases. […]

Abu Dhabi Launches International Carbon Measurement, Reporting and Verification Programme The Environment Agency – Abu Dhabi (EAD) has launched an international standard carbon Measurement, Reporting, and Verification (MRV) programme to address carbon emissions and accelerate the emirate’s transition to a low-carbon economy. This move supports Abu Dhabi’s broader decarbonisation goals, including reducing carbon emissions by […]

Emirati investment firm Kazar is investing $2.5 billion to build a hybrid renewable energy station in Egypt’s Zafarana region. The project, a collaboration with the Egyptian government, will deliver a total capacity of 3.1 gigawatts—2 GW from solar energy and 1.1 GW from wind energy—making it a key addition to Egypt’s renewable energy infrastructure. The station will operate […]

by venturebeat — In a development straight out of science fiction, Endiatx, a pioneering medical technology company, is making significant strides in bringing its robotic pill to market. The company’s CEO, Torrey Smith, recently sat down with VentureBeat to share exciting updates on their progress, nearly two years after our initial coverage of the startup’s ambitious vision. Founded in 2019, Endiatx has been steadily working towards realizing the fantastic voyage of miniaturized robots navigating the human body for diagnostic and therapeutic purposes. Their flagship product, the PillBot, is an ingestible robotic capsule equipped with cameras, sensors, and wireless communication capabilities, allowing doctors to examine the gastrointestinal tract with unprecedented precision and control.

In the interview, Smith revealed that Endiatx has raised $7 million in funding to date, with the largest investment of $1.5 million coming from Singapore-based Verge Health Tech Fund. This injection of capital has propelled the company forward, enabling them to refine their technology and conduct clinical trials. Join enterprise leaders in San Francisco from July 9 to 11 for our flagship AI event. Connect with peers, explore the opportunities and challenges of Generative AI, and learn how to integrate AI applications into your industry. Register Now “We’re currently in clinical trials with our pill bot technology,” Smith explained. “We’ll be starting pivotal trials at a leading U.S. medical institution in Q3/Q4.” Though Smith did not name the institution due to confidentiality agreements, he hinted that it is a renowned facility known for its expertise in gastroenterology. The PillBot has come a long way since its inception. The current prototype measures just 13mm by 30mm and boasts impressive capabilities. “It can transmit high-res video at 2.3 megapixels per second, and we have plans to quadruple that video quality soon,” Smith enthused. The CEO himself has played a vital role in testing, having swallowed 43 PillBots to date, including live on stage in front of a stunned audience.